Group One Trading
DMK

Group One Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Group One Trading’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-70,500
Closed -$49.4K – 8264
2023
Q4 		$49.4K Sell
70,500
-300
-0.4% -$174 ﹤0.01% 5069
2023
Q3 		$48.7K Sell
70,800
-500
-0.7% -$639 ﹤0.01% 5118
2023
Q2 		$170K Buy
71,300
+70,246
+6,665% +$300K ﹤0.01% 4108
2023
Q1 		$8.55K Sell
1,054
-4,306
-80% -$57.2K ﹤0.01% 6023
2022
Q4 		$63.5K Sell
5,360
-44
-0.8% -$503 ﹤0.01% 4814
2022
Q3 		$75K Sell
5,404
-489
-8% -$12.6K ﹤0.01% 5054
2022
Q2 		$207K Sell
5,893
-1,597
-21% -$49.8K ﹤0.01% 4277
2022
Q1 		$299K Buy
7,490
+267
+4% +$11.5K ﹤0.01% 4376
2021
Q4 		$306K Sell
7,223
-8,516
-54% -$531K ﹤0.01% 4641
2021
Q3 		$1.07M Sell
15,739
-281
-2% -$20.6K ﹤0.01% 3342
2021
Q2 		$1.23M Buy
16,020
+11,094
+225% +$676K ﹤0.01% 3161
2021
Q1 		$324K Sell
4,926
-2,058
-29% -$160K ﹤0.01% 4511
2020
Q4 		$237K Sell
6,984
-14,453
-67% -$643K ﹤0.01% 3937
2020
Q3 		$1.18M Buy
21,437
+12,420
+138% +$736K ﹤0.01% 2053
2020
Q2 		$339K Buy
9,017
+8,537
+1,779% +$292K ﹤0.01% 2938
2020
Q1 		$12K Sell
480
-951
-66% -$40.4K ﹤0.01% 4502
2019
Q4 		$70K Buy
+1,431
New +$69.4K ﹤0.01% 3854
2019
Q3 		– Sell
-196
Closed -$18K – 5679
2019
Q2 		$18K Sell
196
-918
-82% -$112K ﹤0.01% 4216
2019
Q1 		$165K Buy
1,114
+1,058
+1,889% +$205K ﹤0.01% 2848
2018
Q4 		$9K Sell
56
-564
-91% -$108K ﹤0.01% 4317
2018
Q3 		$152K Sell
620
-186
-23% -$44K ﹤0.01% 3215
2018
Q2 		$180K Buy
806
+340
+73% +$91K ﹤0.01% 3135
2018
Q1 		$114K Buy
466
+19
+4% +$4.99K ﹤0.01% 3172
2017
Q4 		$138K Buy
447
+193
+76% +$63.5K ﹤0.01% 3165
2017
Q3 		$93K Sell
254
-493
-66% -$175K ﹤0.01% 3288
2017
Q2 		$272K Buy
747
+381
+104% +$114K ﹤0.01% 2424
2017
Q1 		$109K Buy
366
+229
+167% +$57.8K ﹤0.01% 2919
2016
Q4 		$30K Sell
137
-129
-48% -$25.9K ﹤0.01% 3533
2016
Q3 		$64K Buy
266
+35
+15% +$7.27K ﹤0.01% 3200
2016
Q2 		$45K Buy
231
+38
+20% +$17.5K ﹤0.01% 3368
2016
Q1 		$83K Hold
193
– – ﹤0.01% 2957
2015
Q4 		$73K Buy
+193
New +$60.5K ﹤0.01% 3191
2015
Q1 		– Sell
-49
Closed -$21K – 5301
2014
Q4 		$21K Buy
49
+23
+88% +$7.31K ﹤0.01% 3924
2014
Q3 		$8K Sell
26
-13
-33% -$3.81K ﹤0.01% 4574
2014
Q2 		$13K Sell
39
-2
-5% -$785 ﹤0.01% 4416
2014
Q1 		$18K Buy
+41
New +$18.6K ﹤0.01% 4312

Other funds holding DMK

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Group One Trading's DMK Position: Q1 2024 in Review

Group One Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 94 shares — an estimated $66 sold.

Group One Trading first reported a position in DMK in Q1 2014 and held it in 27 quarters. The position peaked at $535K in Q2 2017. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Group One Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 94 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $66.
  • Group One Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 27 quarters.
  • Group One Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $535K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.